Danish drugmaker faces ‘unprecedented pricing pressure’, says chief executive
Science minister Patrick Vallance says Department of Health will fund the extra spending out of its existing budget
Pharmaceutical company’s stock price move diverges from rival Merck as both groups bolster new treatment pipelines
New chief must prove pharma group can offset patent expiries and hit ambitious growth targets
Drugmaker expands push into fast-growing market
Medicines watchdog urges vigilance over rare but serious side effect of GLP-1 medicines
The success of weight-loss drugs has driven demand for injectable compounds that claim to improve everything from sleep to skin
Digital drugs that report when we’ve taken our medication are not without their trade-offs
A shortage of late-stage capital pushes the biggest prizes into US hands
Faster trials and lower costs are drawing western multinationals as they seek new treatments
Big pharma groups look to boost line-up as they confront patent cliff for blockbuster treatments
Pharmaceutical companies seek to make up lost revenue after striking deals with Donald Trump to lower costs in US
Focusing on Novo Nordisk, Aimee Donnellan’s book ranges across R&D, patents, medical effects and the stigma attached to obesity
Jonathan Benger tells FT that health service payments should not rise for years to come
Buyout of UK-listed group would be latest private equity deal for European public company
One of the appeals of the jab business — its dependability — is under threat
A gathering of pharmaceutical executives comes as the sector has rebounded from uncertainty over Trump’s policies
Plus, Merck is in talks for a cancer drugmaker and hedge funds spar over credit default swaps
US company is attempting to acquire the maker of a new treatment for pancreatic cancer
Experts say health authorities need plans to deal with people coming off medicines such as Ozempic and Wegovy
Drug could provide a cure for condition that affects more than 250mn people
Dark Blue Therapeutics was spun out of an Oxford university incubator in 2022
Shots against diseases such as polio and chickenpox will only be suggested for those considered high risk
Lowest doses of Wegovy in oral form will start at $149 a month for American users until April
More drugs entering middle or late-stage development drive up demand
